According to ImmunoPrecise Antibodies's latest financial reports the company's total assets are $58.71 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-04-30 | $57.38 M | -21.24% |
2022-04-30 | $72.86 M | 33.58% |
2021-04-30 | $54.54 M | 177.58% |
2020-04-30 | $19.65 M | -7.11% |
2019-04-30 | $21.15 M | 10.53% |
2018-04-30 | $19.14 M | 564.57% |
2017-04-30 | $2.88 M | 161.69% |
2016-04-30 | $1.1 M | |
2015-12-31 | $0.01 M | -72.15% |
2014-12-31 | $0.03 M | -70.27% |
2013-12-31 | $0.13 M | 165.98% |
2012-12-31 | $0.05 M | -44.96% |
2011-12-31 | $0.09 M | -66.02% |
2010-12-31 | $0.26 M | -94.88% |
2009-12-31 | $5.25 M | -7.9% |
2008-12-31 | $5.7 M | 10.26% |
2007-12-31 | $5.17 M | 3.05% |
2006-12-31 | $5.02 M | 44.51% |
2005-12-31 | $3.47 M | -2.4% |
2004-12-31 | $3.55 M | 219.63% |
2003-12-31 | $1.11 M | 70.06% |
2002-12-31 | $0.65 M | 2.02% |
2001-12-31 | $0.64 M |